China Universal Asset Management Co., Ltd. Kodiak Sciences Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$1.8 - $7.49 $1,193 - $4,965	663 Added 96.65%	1,349 $2,000
Q3 2023 Oct 30, 2023	BUY	$1.8 - $7.49 $1,193 - $4,965	663 Added 96.65%	1,349 $2,000
Q2 2023 May 21, 2024	SELL	$4.3 - $9.48 $94 - $208	-22 Reduced 3.11%	686 $4,000
Q2 2023 Jul 27, 2023	SELL	$4.3 - $9.48 $94 - $208	-22 Reduced 3.11%	686 $5,000
Q1 2023 May 21, 2024	BUY	$4.81 - $8.88 $846 - $1,562	176 Added 33.08%	708 $4,000
Q1 2023 Apr 27, 2023	BUY	$4.81 - $8.88 $846 - $1,562	176 Added 33.08%	708 $4,000
Q4 2022 May 21, 2024	BUY	$6.52 - $8.05 $3,468 - $4,282	532 New	532 $3,000
Q4 2022 Jan 31, 2023	BUY	$6.52 - $8.05 $293 - $362	45 Added 9.24%	532 $4,000
Q3 2022 Oct 21, 2022	BUY	$7.57 - $12.5 $3,686 - $6,087	487 New	487 $4,000

Others Institutions Holding KOD

# of Institutions

Shares Held

39M

Call Options Held

6.5K

Put Options Held

5.8K

Baker Bros. Advisors LP New York, NY

17.3M
Shares

$151 Million
0.48% of portfolio
Black Rock Inc. New York, NY

3.85M
Shares

$33.7 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.95M
Shares

$17.1 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

1.69M
Shares

$14.7 Million
0.0% of portfolio
Iconiq Capital, LLC San Francisco, CA

1.02M
Shares

$8.9 Million
0.06% of portfolio

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account